Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131951) titled 'The effect of Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors on Diabetic Retinal Disease' on Sept. 8.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Department of Ophthalmology and Visual Sciences (DOVS), Chinese University of Hong Kong
Condition:
Diabetes retinopathy
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-10-01
Target Sample Size: Observation group:500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=320678
Published by HT Digital...